Longfellow Investment Management’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Longfellow Investment Management’s Portfolio NRXPW Stock Details NRXPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11,300	Closed	-$3K	–	528
2020 Q3	$3K	Hold	11,300	–	–	﹤0.01%	115
2020 Q2	$5K	Hold	11,300	–	–	﹤0.01%	122
2020 Q1	$1K	Hold	11,300	–	–	﹤0.01%	123
2019 Q4	$2K	Hold	11,300	–	–	﹤0.01%	113
2019 Q3	$2K	Hold	11,300	–	–	﹤0.01%	118
2019 Q2	$2K	Sell	11,300 -45,200	-80%	-$8K	﹤0.01%	105
2019 Q1	$10K	Hold	56,500	–	–	0.01%	116
2018 Q4	$22K	Hold	56,500	–	–	0.01%	100
2018 Q3	$25K	Buy	+56,500	New	+$25.7K	0.01%	106

Other funds holding NRXPW

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Longfellow Investment Management's NRXPW Position: Q4 2020 in Review

Longfellow Investment Management sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q4 2020, closing a stake of 11,300 shares — an estimated $3K sold.

Longfellow Investment Management first reported a position in NRXPW in Q3 2018 and held it in 9 quarters. The position peaked at $25K in Q3 2018. 2 funds tracked by Wall St. Rank hold NRXPW as of Q4 2020.

Longfellow Investment Management reported no remaining NRX Pharmaceuticals Warrant position as of Q4 2020 after selling out during the quarter.
Longfellow Investment Management sold 11,300 NRX Pharmaceuticals Warrant shares in Q4 2020, an estimated $3K.
Longfellow Investment Management first reported a position in NRX Pharmaceuticals Warrant in Q3 2018 and held it in 9 quarters.
Longfellow Investment Management's NRX Pharmaceuticals Warrant position peaked at $25K in Q3 2018.
2 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q4 2020.

Based on Longfellow Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.